Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the cast-hf trial): study protocol for a randomized controlled trial—an update

HIGHLIGHTS

• who: Felix Nu00e4gele from the Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria have published the Article: Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trialu2014an update, in the Journal: (JOURNAL)
• what: The aim of the CAST-HF trial, therefore, is to evaluate the effect of direct epicardial shockwave therapy adjunctive to CABG surgery in patients suffering from markedly reduced ejection fraction. Criteria for discontinuing or modifying allocated interventions {11b} Subjects will exit . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.